Anderson AJ, Krasnow SH, Boyer MW, Cutler DJ, Jones BD, Citron ML, Ortega LG, Cohen MH (1989) Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest 95:71-75
Barrios CH, Zuke JE, Blaes B, Hirsch JD, Lyss AP (1992) Evaluation of an implantable venous access system in a general oncology population. Oncology 49:474-478
Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, Greco FA, Huberman M, Moore C (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 112:423-428
Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nole F, Andreoni B (1998) Totally implantable venous access ports for long term chemotherapy. Ann Oncol 9:767-773
Boraks P, Seale J, Price J, Bass G, Ethell M, Keeling D, Mahendra P, Baglin T, Marcus R (1998) Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 101:483-486
Brown-Smith JK, Stoner MH, Barley ZA (1990) Tunnelled catheter thrombosis: factors related to incidence. Oncol Nurs Forum 17:543-549
Chevrel JP, Destable MD, Breau JL, Dilin C (1988) Boitiers de perfusion implantables. Presse Med 17:17-20
De Cicco M, Matovic M, Balestreri L, De Angelis V, Fracasso A, Morassut S, Coran F, Babare R, Buonadonna A, Testa V (1995) Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients. Thromb Res 78:127-137
De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S, Testa V (1997) Central venous thrombosis: an early and frequent complication in cancer patients bearing long term silastic catheter. A prospective study. Thromb Res 86:101-113
Debets JM, Wils JA, Schlangen JT (1995) A rare complication of implanted central venous access devices: catheter fracture and embolization. Support Care Cancer 3:432-434
Devie-Hubert I, Carlier M, Pozzo Di Borgo C (1996) Les thromboses veineuses sur catheter central en cancerologie. Rev Med Interne 17:821-825
Eastridge BJ, Lefor AT (1995) Complications of indwelling venous access devices in cancer patients. J Clin Oncol 13:233-238
Guenier C, Nogaret JM, Ferreira J, Lorent I, Pector JC (1990) Voies d'abord veineux en oncologie par chambe implantable. Ann Chir 44:388-391
Horne MK 3rd, May DJ, Alexander HR, Steinhaus EP, Whitman ED, Chang RC, Doppman JL (1995) Venographic surveillance of tunnelled venous access devices in adult oncology patients. Ann Surg Oncol 2:174-178
Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW (1998) Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg 22:12-16
Lagro SW, Verdonck LF, Borel Rinkes IH, Dekker AW (2000) No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients. Bone Marrow Transplant 26:1103-1106
Licciardello JT, Moake JL, Rudy CK, Karp DD, Hong WK (1985) Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy. Oncology 42:296-300
Lokich JJ, Becker B (1983) Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 52:1586-1589
Massicotte P, Julian JA, Gent M, Shields K, Marzinotto V, Szechtman B, Chan AK, Andrew M (2003) An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res 109:101-108
Mismetti P, Mille D, Laporte S, Charlet V, Buchmuller-Cordier A, Jacquin JP, Fournel P, Dutrey-Dupagne C, Decousus H; CIP Study Group (2003) Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 88:67-73
Monreal M, Lafoz E, Ruiz J, Valls R, Alastrue A (1991) Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest 99:280-283
Monreal M, Raventos A, Lerma R, Ruiz J, Lafoz E, Alastrue A, Llamazares JF (1994) Pulmonary embolism in patients with upper extremity DVT associated to venous central lines - a prospective study. Thromb Haemost 72:548-550
Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, Abad A (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 75:251-253
Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E (1982) Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 92:706-712
Pector JC (1998) Vascular access problems. Support Care Cancer 6:20-22
Puel V, Caudry M, Le Metayer P, Baste JC, Midy D, Marsault C, Demeaux H, Maire JP (1993) Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 72:2248-2252
Puig-la Calle J Jr, Lopez Sanchez S, Piedrafita Serra E, Allende Honorato L, Artigas Raventos V, Puig la Calle J (1996) Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms. J Surg Oncol 62:273-278
Schwarz RE, Groeger JS, Coit DG (1997) Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer 79:1635-1640
Stas M (1998) Positionering van katheter en poort, Poorten en Katheters voor langdurige I.V. therapie. Universitaire pers Leuven, Leuven
